ACP3
Prostatic acid phosphatase
Also known as: ACP-3, ACPP, PAP, PPAP_HUMAN, TM-PAP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15309
- Gene
- ACP3
- Ensembl
- ENSG00000014257
- Chromosome
- 3
- Canonical length
- 386 aa
- Protein class
- Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is synthesized under androgen regulation and is secreted by the epithelial cells of the prostate gland. An alternatively spliced transcript variant encoding a longer isoform has been found for this gene. This isoform contains a transmembrane domain and is localized in the plasma membrane-endosomal-lysosomal pathway. [provided by RefSeq, Sep 2008]
Canonical amino-acid sequenceUniProt
386 residues, UniProt reviewed canonical sequence.
>P15309|ACP3
1 MRAAPLLLAR AASLSLGFLF LLFFWLDRSV LAKELKFVTL VFRHGDRSPI DTFPTDPIKE
61 SSWPQGFGQL TQLGMEQHYE LGEYIRKRYR KFLNESYKHE QVYIRSTDVD RTLMSAMTNL
121 AALFPPEGVS IWNPILLWQP IPVHTVPLSE DQLLYLPFRN CPRFQELESE TLKSEEFQKR
181 LHPYKDFIAT LGKLSGLHGQ DLFGIWSKVY DPLYCESVHN FTLPSWATED TMTKLRELSE
241 LSLLSLYGIH KQKEKSRLQG GVLVNEILNH MKRATQIPSY KKLIMYSAHD TTVSGLQMAL
301 DVYNGLLPPY ASCHLTELYF EKGEYFVEMY YRNETQHEPY PLMLPGCSPS CPLERFAELV
361 GPVIPQDWST ECMTTNSHQG TEDSTDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 3,410 nTPM
Expression across tissuesHPA
Tissue
- prostate: 3,410 nTPM
- esophagus: 43 nTPM
- kidney: 27 nTPM
- skin: 26 nTPM
- bone marrow: 17 nTPM
- epididymis: 16 nTPM
Single-cell type
- prostatic glandular cells: 24,145 nCPM
- basal prostatic cells: 266 nCPM
- prostatic club cells: 236 nCPM
- esophageal apical cells: 143 nCPM
- loop of henle epithelial cells: 122 nCPM
- esophageal suprabasal cells: 93 nCPM
Immune cell
- eosinophil: 140 nTPM
- myeloid DC: 35 nTPM
- classical monocyte: 30 nTPM
- intermediate monocyte: 27 nTPM
- neutrophil: 27 nTPM
- non-classical monocyte: 26 nTPM
Brain region
- white matter: 3.8 nTPM
- hypothalamus: 3.7 nTPM
- medulla oblongata: 3.5 nTPM
- pons: 3.1 nTPM
- cerebral cortex: 3 nTPM
- choroid plexus: 3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACP3.
Disease | ImmuneIEDB
Conditions an epitope on ACP3 was assayed in.
- prostate cancer B and T cell
- castration-resistant prostate carcinoma B and T cell
- prostatitis T cell
- cancer B and T cell
- esophageal cancer B and T cell
- carcinoma B and T cell
- colorectal cancer B and T cell
- prostatic urethral cancer B and T cell
- pancreatic carcinoma B cell
- biliary tract cancer B and T cell
- lung small cell carcinoma B cell
- adult hepatocellular carcinoma B cell
- triple-receptor negative breast cancer B and T cell
- Her2-receptor negative breast cancer B and T cell
- Her2-receptor positive breast cancer B and T cell
- hematologic cancer B cell
- hepatocellular carcinoma B cell
- leiomyosarcoma B and T cell
- liposarcoma B and T cell
- osteosarcoma B and T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenosine metabolic process
- lipid metabolic process
- nucleotide metabolic process
- positive regulation of adenosine receptor signaling pathway
- purine nucleobase metabolic process
- regulation of sensory perception of pain
- thiamine metabolic process
Molecular functions
- 5'-nucleotidase activity
- acid phosphatase activity
- choline binding
- identical protein binding
- lysophosphatidic acid phosphatase activity
- molecular adaptor activity
- phosphatase activity
- protein homodimerization activity
- protein tyrosine phosphatase activity
- thiamine phosphate phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACP3 as an antibody target. Whether an autoantibody or antibody against ACP3 could matter depends on whether native ACP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACP3 is annotated at the cell surface, where native ACP3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ACP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...